Attached files
| file | filename |
|---|---|
| EX-10.49 - EXHIBIT 10.49 - Bionano Genomics, Inc | bngo-ex1049x20191231.htm |
| EX-32.1 - EXHIBIT 32.1 - Bionano Genomics, Inc | bngo-ex321x20191231.htm |
| EX-31.1 - EXHIBIT 31.1 - Bionano Genomics, Inc | bngo-ex311x20191231.htm |
| EX-4.16 - EXHIBIT 4.16 - Bionano Genomics, Inc | bngo-ex416x20191231.htm |
| 10-K - 10-K - Bionano Genomics, Inc | bngo10k-20191231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement Nos. 333-227073 and 333-230589 on Form S-8 of our report dated March 10, 2020, relating to the financial statements of Bionano Genomics, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP
San Diego, California
March 10, 2020